Insulet CORP Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting a 1.4% beneficial ownership of Insulet Corp's common stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 5.6% of Insulet Corp's common stock as of March 31, 2026.

Vanguard Capital Management has reported a beneficial ownership of 7.49% in Insulet Corp's common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership of Insulet Corp common stock following an internal realignment.

FMR LLC and Abigail P. Johnson report a 9.0% beneficial ownership stake in Insulet Corp as of December 31, 2025, in an amended Schedule 13G filing.

The Vanguard Group has reported a 12.49% beneficial ownership stake in Insulet Corp, holding 8,796,200 shares of common stock.

Capital Research Global Investors has filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in Insulet Corp. as of June 30, 2025.

Capital Research Global Investors has filed an Amendment No. 10 to its Schedule 13G, disclosing a beneficial ownership of 8.7% in Insulet Corp.'s common stock as of March 31, 2025.